PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsOcuphire Pharma
Ocuphire Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
RyzumviPhentolamine2023-09-252034-2039
Necrosis
,
Extravasation of diagnostic and therapeutic materials
,
Malignant hypertension
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Phentolamine
obesity
,
healthy volunteers/patients
,
heart failure
,
type 1 diabetes mellitus
,
hypoglycemia
,
chronic obstructive pulmonary disease
,
pulmonary arterial hypertension
,
obstructive lung diseases
,
vasculogenic impotence
,
stem cell transplantation
,
insulin resistance
,
cardiovascular diseases
,
obstructive sleep apnea
,
sleep apnea syndromes
,
menopause
,
erectile dysfunction
,
prostatic neoplasms
,
ocular hypertension
,
glaucoma
,
open-angle glaucoma
,
hypesthesia
,
hypertension
,
pathologic dilatation
,
dilatation
,
mydriasis
,
stroke
,
presbyopia
,
covid-19
,
drug-related side effects and adverse reactions
,
ischemic stroke
,
ischemia
,
vision disorders
,
respiratory distress syndrome
,
coronavirus infections
,
respiratory insufficiency
,
acute lung injury
,
lung injury
,
newborn respiratory distress syndrome
,
soft tissue injuries
,
acute kidney injury
,
wounds and injuries
,
acute coronary syndrome
,
coronary artery disease
,
night blindness
,
mesopic vision
,
vasodilation
,
dental anesthesia
,
local anesthesia
,
vasoconstriction
,
pre-eclampsia
,
eclampsia
,
multiple myeloma
,
plasma cell neoplasms
,
neoplasm metastasis
,
pregnancy complications
,
hemorrhage
,
cerebral hemorrhage
,
pneumonia
,
community-acquired pneumonia
,
intracranial hemorrhages
,
diabetes mellitus
,
inflammation
,
hypotension
,
preoperative period
,
pathologic constriction
,
miosis
Alfacalcidol
vitamin d deficiency
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
inflammation
,
rickets
,
avitaminosis
,
lactation
,
chronic renal insufficiency
,
kidney diseases
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
neoplasm metastasis
,
renal dialysis
,
rheumatoid arthritis
,
arthritis
,
joint diseases
Lactams
healthy volunteers/patients
,
chronic kidney failure
,
kidney diseases
,
retinal diseases
,
neoplasms
,
renal insufficiency
,
sepsis
,
gram-negative bacterial infections
,
toxemia
,
bacterial infections
,
soft tissue infections
,
bacterial pneumonia
,
community-acquired infections
,
infections
,
communicable diseases
,
pneumonia
,
intraabdominal infections
,
urinary tract infections
,
healthcare-associated pneumonia
,
ventilator-associated pneumonia
,
pyelonephritis
,
bacteremia
,
respiratory distress syndrome
,
acute lung injury
,
cross infection
,
newborn respiratory distress syndrome
APX-3330
neoplasms
,
macular edema
,
retinal diseases
,
diabetic retinopathy
Demand
erectile dysfunction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use